Tag: Alzheimer’s
Age, Sex, APOE Genotype Identify Alzheimer’s, Dementia Risk
Three factors help identify absolute 10-year risk of Alzheimer's disease, all dementia for different groups
Prevalence of Alzheimer’s, Related Dementia Set to Double
Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060
Retinal Abnormalities May Indicate Preclinical Alzheimer’s
Retinal microvascular abnormalities seen in cognitively normal individuals with biomarkers for AD
PET Imaging Can Measure Synaptic Loss From Alzheimer’s
Team found SV2A-specific binding correlated with memory
Increased Levels of Human Herpesvirus ID’d in Alzheimer’s
Disruption of molecular, genetic, clinical networks by human herpesvirus in brains of subjects with AD
Experimental Drug Slows Mental Decline in Alzheimer’s Patients
However, the Phase 2 study of BAN2401 did not meet its primary end point
Focused Ultrasound May Briefly Open Blood-Brain Barrier
Finding could be a game-changer for the treatment of neurological diseases such as Alzheimer's
Lifetime Risks Temper Biomarker Tests for Alzheimer Dz Dementia
Those younger than 85 years with MCI, amyloidosis, neurodegeneration have risk >50 percent
Women Have Stronger Link Between APOE-ε4, CSF Tau Levels
Sex differences were not seen in the correlation between APOE and neurofibrillary tangle burden
apoE Aggregation May Impact apoE-Mediated Plaque Formation
Anti-human apoE-4 antibody preferentially binds unlipidated aggregated apoE over lipidated version
